• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 425 filed by Gentherm Inc

    2/19/26 5:07:11 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $THRM alert in real time by email
    425 1 q4_2025_thrm_8k_-_425.htm 425 425

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): February 19, 2026

     

     

    GENTHERM INCORPORATED

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Michigan

    0-21810

    95-4318554

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    28875 Cabot Drive

     

    Novi, Michigan

     

    48377

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: (248) 348-9735

     

    N/A

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☒Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Common Stock, no par value

     

    THRM

     

    The Nasdaq Global Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     


     

     

    Item 2.02 Results of Operations and Financial Condition.

    On February 19, 2026, Gentherm Incorporated (the “Company”) publicly announced its financial results for the fourth quarter and full year for 2025 and provided 2026 guidance and a preliminary revenue outlook for 2027. A copy of the Company’s news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

    Item 7.01 Regulation FD Disclosure.

    On February 19, 2026 at 8:00 a.m. Eastern Time, the Company will host a conference call to discuss the fourth quarter and full year 2025 financial results and 2026 guidance.

    A copy of the supplemental materials that will be used during the conference call can be accessed on the Events page of the Investors section of the Company’s website at www.gentherm.com. The content of the Company’s website is not incorporated herein by reference.

    The information in Items 2.02 and 7.01 herein and the attached exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly stated by specific reference in such filing.

    NO OFFER OR SOLICITATION

    This Current Report on Form 8-K is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or exchange any securities or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. It does not constitute a prospectus or prospectus equivalent document. No offering or sale of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, and otherwise in accordance with applicable law.

    Additional Information and Where to Find It

    In connection with the Proposed Transaction among Gentherm, Modine and Modine’s Performance Technologies business (“SpinCo”), the parties intend to file relevant materials with the SEC, including, among other filings, a registration statement on Form S-4 to be filed by Gentherm (the “Form S-4”) that will include a preliminary proxy statement/prospectus of Gentherm and a definitive proxy statement/prospectus of Gentherm, the latter of which will be mailed to shareholders of Gentherm, and a registration statement on Form 10 to be filed by SpinCo that will incorporate by reference certain portions of the Form S-4 and will serve as an information statement/prospectus in connection with the spin-off of SpinCo from Modine. INVESTORS AND SECURITY HOLDERS OF GENTHERM AND MODINE ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS, THE INFORMATION STATEMENT/PROSPECTUS AND ANY OTHER DOCUMENTS THAT WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT GENTHERM, MODINE, SPINCO, THE PROPOSED TRANSACTION AND RELATED MATTERS. Investors and security holders will be able to obtain free copies of the Form S-4 and the proxy statement/prospectus (when available) and other documents filed with the SEC by Gentherm, Modine or SpinCo through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by Gentherm will be available free of charge on Gentherm’s website at ir.Gentherm.com under the tab “Financial Info” and under the heading “SEC Filings.” Copies of the documents filed with the SEC by Modine and SpinCo will be available free of charge on Modine’s website at investors.Modine.com under the tab “Financials” and under the heading “SEC Filings.”

    Participants in the Solicitation

    Gentherm and Modine and their respective directors and executive officers and other members of management and employees may be considered participants in the solicitation of proxies from Gentherm’s shareholders in connection with the Proposed Transaction under the rules of the SEC. Information about the directors and executive officers of Gentherm is set forth in its Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the SEC on February 19, 2025, and its proxy statement for its 2025 annual meeting of shareholders, which was filed with the SEC on March 27, 2025. To the extent holdings of Gentherm’s securities by its directors or executive

     


     

     

    officers have changed since the amounts set forth in such filings, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Beneficial Ownership on Form 4 filed with the SEC. Information about the directors and executive officers of Gentherm and other information regarding the potential participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the Proposed Transaction. Information about the directors and executive officers of Modine is set forth in its Annual Report on Form 10-K for the year ended March 31, 2025, which was filed with the SEC on May 21, 2025, and its proxy statement for its 2025 annual meeting of shareholders, which was filed with the SEC on July 9, 2025. To the extent holdings of Modine’s securities by its directors or executive officers have changed since the amounts set forth in such filings, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Beneficial Ownership on Form 4 filed with the SEC. You may obtain these documents (when they become available) free of charge through the website maintained by the SEC at www.sec.gov and from Gentherm’s website and Modine’s website as described above.

    Cautionary Statement Regarding Forward-Looking Statements

    This Current Report on Form 8-K includes “forward-looking statements” as that term is defined in Section 27A of the Securities Act, and Section 21E of the Exchange Act, including statements regarding the Proposed Transaction among Gentherm, Modine and SpinCo. These forward-looking statements generally are identified by the words “believe,” “feel,” “project,” “expect,” “anticipate,” “appear,” “estimate,” “forecast,” “outlook,” “target,” “endeavor,” “seek,” “predict,” “intend,” “suggest,” “strategy,” “plan,” “may,” “could,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” or the negative thereof or variations thereon or similar terminology generally intended to identify forward-looking statements. All statements, other than historical facts, including, but not limited to, statements regarding the expected timing and structure of the Proposed Transaction, the ability of the parties to complete the Proposed Transaction, the expected benefits of the Proposed Transaction, including future financial and operating results, anticipated strategic benefits of the Proposed Transaction, the amount and timing of synergies from the Proposed Transaction, the tax consequences of the Proposed Transaction, the terms and scope of the expected financing in connection with the Proposed Transaction, the aggregate amount of indebtedness of the combined company following the closing of the Proposed Transaction, the combined company’s plans, objectives, expectations and intentions, legal, economic and regulatory conditions, and any assumptions underlying any of the foregoing, are forward-looking statements.

    These forward-looking statements are based on Gentherm’s and Modine’s current expectations and are subject to risks and uncertainties surrounding future expectations generally. Actual results could differ materially from those currently anticipated due to a number of risks and uncertainties, many of which are beyond Gentherm’s and Modine’s control. None of Gentherm, Modine, SpinCo or any of their respective directors, executive officers, advisors or representatives make any representation or provide any assurance or guarantee that the occurrence of the events expressed or implied in any forward-looking statements will actually occur, or if any of them do occur, what impact they will have on the business, results of operations or financial condition of Gentherm, Modine or the combined business. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements, including developments that could have a material adverse effect on Gentherm’s and Modine’s businesses and the ability to successfully complete the Proposed Transaction and realize its benefits. The inclusion of such statements should not be regarded as a representation that such plans, estimates or expectations will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) that one or more closing conditions to the Proposed Transaction, including certain regulatory approvals, may not be satisfied or waived, on a timely basis or otherwise, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the Proposed Transaction, may require conditions, limitations or restrictions in connection with such approvals or that the required approval by the shareholders of Gentherm may not be obtained; (2) the risk that the Proposed Transaction may not be completed on the terms or in the time frame expected by Gentherm, Modine and SpinCo, or at all; (3) unexpected costs, charges or expenses resulting from the Proposed Transaction; (4) uncertainty of the expected financial performance of the combined company following completion of the Proposed Transaction; (5) failure to realize the anticipated benefits of the Proposed Transaction, including as a result of delay in completing the Proposed Transaction or integrating the businesses of Gentherm and SpinCo, on the expected timeframe or at all; (6) the ability of the combined company to implement its business strategy; (7) difficulties and delays in the combined

     


     

     

    company achieving revenue and cost synergies; (8) inability of the combined company to retain and hire key personnel; (9) the occurrence of any event that could give rise to termination of the Proposed Transaction; (10) the risk that shareholder litigation in connection with the Proposed Transaction or other litigation, settlements or investigations may affect the timing or occurrence of the Proposed Transaction or result in significant costs of defense, indemnification and liability; (11) evolving legal, regulatory and tax regimes; (12) changes in general economic and/or industry specific conditions or any volatility resulting from the imposition of and changing policies, including those policies with respect to tariffs; (13) actions by third parties, including government agencies; (14) the risk that the anticipated tax treatment of the Proposed Transaction is not obtained; (15) the risk of greater than expected difficulty in separating the business of SpinCo from the other businesses of Modine; (16) risks related to the disruption of management time from ongoing business operations due to the pendency of the Proposed Transaction, or other effects of the pendency of the Proposed Transaction on the relationship of any of the parties to the Proposed Transaction with their employees, customers, suppliers, or other counterparties; and (17) other risk factors detailed from time to time in Gentherm’s and Modine’s reports filed with the SEC, including Gentherm’s and Modine’s annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and other documents filed with the SEC, including documents that will be filed with the SEC in connection with the Proposed Transaction. The foregoing list of important factors is not exclusive.

    Any forward-looking statements speak only as of the date of this Current Report on Form 8-K. None of Gentherm, Modine or SpinCo undertakes, and each party expressly disclaims, any obligation to update any forward-looking statements, whether as a result of new information or development, future events or otherwise, except as required by law. Readers are cautioned not to place undue reliance on any of these forward-looking statements.

    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit 99.1

    Company news release dated February 19, 2026 concerning financial results and guidance

    Exhibit 104

     

    Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

     

    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    GENTHERM INCORPORATED

     

     

     

     

    By:

     

    /s/ Wayne Kauffman

     

     

     

    Wayne Kauffman

     

     

     

    Senior Vice President, General Counsel and Secretary

    Date: February 19, 2026

     

     

     

     

     


     

    img24726023_0.gif

     

    Exhibit 99.1

    Gentherm Reports 2025 Fourth Quarter and Full Year Results

     

    Achieved Record Annual Revenue of $1.5 Billion

    Increased Full Year Operating Cash Flow 7% Year-over-Year; Reduced Net Leverage to 0.2x

    Establishes 2026 Guidance; Provides Preliminary Revenue Outlook of ~$1.7B for 2027

     

    NOVI, Michigan, February 19, 2026 -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced its financial results for the fourth quarter and full year ended December 31, 2025.

     

    “We made significant progress on our long-term strategic initiatives while executing against our 2025 financial and operational plans. We are intent on transforming Gentherm. Momentum on our adjacent market initiatives continues to build, and our announced combination with Modine Performance Technologies, which is expected to close by the end of the year, will position us as a truly differentiated supplier—one with a stronger product portfolio, broader end‑market diversification, and an enhanced platform for profitable growth,” said Bill Presley, the Company's President and CEO.

     

    Fourth Quarter Highlights

     

    •
    Secured Automotive New Business Awards totaling $485 million in the quarter.
    •
    Selected by a second leading global furniture brand to supply climate and comfort solutions with start of production expected in mid-2026.
    •
    Product revenues of $382.8 million increased 8.5% from $352.9 million in the prior year. Excluding the impact of foreign currency translation, product revenues increased 5.6%, with Automotive increasing 6.0% and Medical decreasing 3.9%.
    •
    Automotive Climate and Comfort Solutions revenue increased 11.1% year over year, or 8.6% excluding the impact of foreign currency translation, outperforming S&P Global’s mid-February light vehicle production report in our relevant markets by 820 basis points.
    •
    Gross margin was 23.7%, compared to 24.4% in the prior year. The decrease was primarily driven by higher material costs, including mix, as well as expenses related to our footprint realignment, partially offset by operating leverage.
    •
    Net income was $3.0 million, compared to $15.3 million in the prior year.
    •
    Adjusted EBITDA was $40.6 million, or 10.6% of revenue, compared to $41.4 million, or 11.7% of revenue, in the prior year.
    •
    GAAP diluted earnings per share was $0.10, compared to $0.49 in the prior year.
    •
    Adjusted diluted earnings per share was $0.49,compared to $0.29 in the prior year.

     

    Full Year 2025 Highlights

     

    •
    Secured Automotive New Business Awards totaling $2.2 billion in the year.
    •
    Product revenues of $1,498.6 million increased 2.9% from $1,456.1 million in the prior year. Excluding the impact of foreign currency translation, product revenues increased 1.8%, with Automotive increasing 1.9% and Medical decreasing 1.3%.
    •
    Gross margin was 24.2%, compared to 25.2% in the prior year. The decrease was primarily driven by higher material costs, including mix, as well as expenses related to our footprint realignment, partially offset by operating leverage.
    •
    Net income was $18.3 million, compared to $64.9 million in the prior year.
    •
    Adjusted EBITDA was $174.8 million, or 11.7% of revenue, compared to $182.9 million, or 12.6% of revenue, in the prior year.
    •
    GAAP diluted earnings per share was $0.59, compared to $2.06 in the prior year.
    •
    Adjusted diluted earnings per share was $2.27,compared to $2.33 in the prior year.

     


     

    img24726023_0.gif

     

    •
    Delivered full year cash flow from operations of $116.8 million, compared to $109.6 million in the prior year.
    •
    Reduced net leverage to ~0.2x and increased liquidity to $468.8 million at year end, compared to ~0.5x and $414.1 million, respectively, at the prior year end.

     

    Presley concluded, “As we begin 2026, our team is united around a clear set of strategic priorities and energized by the momentum we’ve created. We are taking bold, decisive actions that will position Gentherm for sustainable, profitable growth and create long-term shareholder value.”

     

    Guidance

    The Company is providing guidance for full year 2026 and a preliminary revenue outlook for 2027¹:

     

     

     

    As of February 2026

    2026

    Product Revenues

    $1.5B – $1.6B

    Adjusted EBITDA

    $175M – $195M

    Adjusted Free Cash Flow

    $80M – $100M

     

     

     

    2027

    Product Revenues

    ~$1.7B

    ¹2026 guidance based on tariffs currently in effect as of today, our current forecast of customer orders and expectations of near-term conditions, light vehicle production in our relevant markets decreasing at a low single digit rate for full year 2026 versus 2025, and a EUR to USD exchange rate of $1.16/Euro. Assumes an effective tax rate of ~30%. Does not reflect any impact from the planned combination with Modine Performance Technologies.

     

    The Company provides various non-GAAP financial measures in this release. See “Use of Non-GAAP Measures” below for additional information, including definitions, usefulness for investors and limitations, as well as reconciliations below to the most directly comparable GAAP financial measures.

     

    Conference Call

     

    As previously announced, Gentherm will conduct a conference call today at 8:00 am Eastern Time to review these results. The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside the U.S.). The passcode for the live call is 13758613.

     

    A live webcast and one-year archived replay of the call, as well as a copy of the supplemental materials that will be used during the conference call, can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.

     

    A telephonic replay will be available approximately two hours after the call until 11:59 pm Eastern Time on March 5, 2026. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13758613.

     

     


     

    img24726023_0.gif

     

     

    Investor Contact
    Gregory Blanchette
    [email protected] 
    248.308.1702

    Media Contact
    Melissa Fischer
    [email protected] 
    248.289.9702

     

    About Gentherm

    Gentherm (NASDAQ: THRM) is a global market leader of innovative thermal management and pneumatic comfort technologies. Automotive products include Climate Control Seats (CCS®), Climate Control Interiors (CCI™), Lumbar and Massage Comfort Solutions, and Valve Systems. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities across 13 countries. In 2025, the company recorded annual sales of approximately $1.5 billion and secured $2.2 billion in automotive new business awards. For more information, go to www.gentherm.com.

     

    NO OFFER OR SOLICITATION

    This release is not intended to and does not constitute an offer to sell or the solicitation of an offer to buy or exchange any securities or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. It does not constitute a prospectus or prospectus equivalent document. No offering or sale of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act, and otherwise in accordance with applicable law.

     

    Additional Information and Where to Find It

    In connection with the proposed transaction (the “Proposed Transaction”) among Gentherm, Modine Manufacturing Company (“Modine”) and Modine’s Performance Technologies business (“SpinCo”), the parties intend to file relevant materials with the SEC, including, among other filings, a registration statement on Form S-4 to be filed by Gentherm (the “Form S-4”) that will include a preliminary proxy statement/prospectus of Gentherm and a definitive proxy statement/prospectus of Gentherm, the latter of which will be mailed to shareholders of Gentherm, and a registration statement on Form 10 to be filed by SpinCo that will incorporate by reference certain portions of the Form S-4 and will serve as an information statement/prospectus in connection with the spin-off of SpinCo from Modine. INVESTORS AND SECURITY HOLDERS OF GENTHERM AND MODINE ARE URGED TO READ THE PROXY STATEMENT/PROSPECTUS, THE INFORMATION STATEMENT/PROSPECTUS AND ANY OTHER DOCUMENTS THAT WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT GENTHERM, MODINE, SPINCO, THE PROPOSED TRANSACTION AND RELATED MATTERS. Investors and security holders will be able to obtain free copies of the Form S-4 and the proxy statement/prospectus (when available) and other documents filed with the SEC by Gentherm, Modine or SpinCo through the website maintained by the SEC at www.sec.gov. Copies of the documents filed with the SEC by Gentherm will be available free of charge on Gentherm’s website at ir.Gentherm.com under the tab “Financial Info” and under the heading “SEC Filings.” Copies of the documents filed with the SEC by Modine and SpinCo will be available free of charge on Modine’s website at investors.Modine.com under the tab “Financials” and under the heading “SEC Filings.”

     

     


     

    img24726023_0.gif

     

    Participants in the Solicitation

    Gentherm and Modine and their respective directors and executive officers and other members of management and employees may be considered participants in the solicitation of proxies from Gentherm’s shareholders in connection with the Proposed Transaction under the rules of the SEC. Information about the directors and executive officers of Gentherm is set forth in its Annual Report on Form 10-K for the year ended December 31, 2024, which was filed with the SEC on February 19, 2025, and its proxy statement for its 2025 annual meeting of shareholders, which was filed with the SEC on March 27, 2025. To the extent holdings of Gentherm’s securities by its directors or executive officers have changed since the amounts set forth in such filings, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Beneficial Ownership on Form 4 filed with the SEC. Information about the directors and executive officers of Gentherm and other information regarding the potential participants in the proxy solicitations and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement/prospectus and other relevant materials to be filed with the SEC regarding the Proposed Transaction. Information about the directors and executive officers of Modine is set forth in its Annual Report on Form 10-K for the year ended March 31, 2025, which was filed with the SEC on May 21, 2025, and its proxy statement for its 2025 annual meeting of shareholders, which was filed with the SEC on July 9, 2025. To the extent holdings of Modine’s securities by its directors or executive officers have changed since the amounts set forth in such filings, such changes have been or will be reflected on Initial Statements of Beneficial Ownership on Form 3 or Statements of Beneficial Ownership on Form 4 filed with the SEC. You may obtain these documents (when they become available) free of charge through the website maintained by the SEC at www.sec.gov and from Gentherm’s website and Modine’s website as described above.

     

    Forward-Looking Statements

    Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, third party information and projections from sources that management believes to be reputable, as well as other factors we consider appropriate under the circumstances. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward-looking statements, including but not limited to:

     

    •
    macroeconomic, geopolitical and similar global factors in the cyclical Automotive industry;
    •
    the impact of, and our ability to mitigate the effects of, global economic and trade policies, including increases in duties, tariffs and taxation on the import or export of our products related to U.S. trade disputes;
    •
    increasing U.S. and global competition, including with non-traditional entrants;
    •
    our ability to effectively manage new product launches and research and development, and the market acceptance of such products and technologies;
    •
    the evolution and challenges of the automotive industry towards electric vehicles, autonomous vehicles and mobility on demand services, and related consumer behaviors and preferences;
    •
    our ability to convert automotive new business awards into product revenues;
    •
    the constraints in the supply chain environment, and inflationary and other cost pressures;
    •
    the production levels of our major customers and OEMs in our relevant markets and sudden fluctuations in such production levels;

     


     

    img24726023_0.gif

     

    •
    our business in China, which is subject to unique operational, competitive, geopolitical, regulatory and economic risks;
    •
    the impact of our global operations, including our cost structure and global manufacturing footprint, operations within Ukraine, and foreign currency and exchange risk;
    •
    our product quality and safety and impact of product safety recalls and alleged defects in products;
    •
    our ability to attract and retain highly skilled employees and wage inflation;
    •
    a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, such as recent labor strikes among certain OEMs and suppliers;
    •
    our achievement of product cost reductions to offset customer-imposed price reductions or other pricing pressures;
    •
    our ability to execute efforts to optimize our global supply chain and manufacturing footprint, including opening new facilities and transferring production;
    •
    our ability to source, consummate, integrate and achieve planned benefits of strategic acquisitions, investments and, as applicable, exits;
    •
    any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks, including risks associated with use of artificial intelligence capabilities in our business operations;
    •
    any loss or insolvency of our key customers and OEMs, or key suppliers;
    •
    our ability to project future sales volume based on third-party information, based on which we manage our business;
    •
    the protection of our intellectual property in certain jurisdictions;
    •
    our compliance with global anti-corruption laws and regulations;
    •
    legal and regulatory proceedings and claims involving us or one of our major customers;
    •
    the extensive regulation of our patient temperature management business;
    •
    risks associated with our manufacturing processes;
    •
    the effects of climate change and regulatory and stakeholder-imposed requirements to address climate change and other sustainability issues;
    •
    our product quality and safety;
    •
    our borrowing availability under our revolving credit facility, as well as the ability to access the capital markets, to support our planned growth; and
    •
    our indebtedness and compliance with our debt covenants.

    Furthermore, important factors related to the Proposed Transaction could cause actual results to differ materially from those currently anticipated, including:

     

    •
    that one or more closing conditions to the Proposed Transaction, including certain regulatory approvals, may not be satisfied or waived, on a timely basis or otherwise, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the Proposed Transaction, may require conditions, limitations or restrictions in connection with such approvals or that the required approval by the shareholders of Gentherm may not be obtained;
    •
    the risk that the Proposed Transaction may not be completed on the terms or in the time frame expected by Gentherm, Modine and SpinCo, or at all;
    •
    unexpected costs, charges or expenses resulting from the Proposed Transaction;
    •
    uncertainty of the expected financial performance of the combined company following completion of the Proposed Transaction;
    •
    failure to realize the anticipated benefits of the Proposed Transaction, including as a result of delay in completing the Proposed Transaction or integrating the businesses of Gentherm and SpinCo, on the expected timeframe or at all;
    •
    the ability of the combined company to implement its business strategy;
    •
    difficulties and delays in the combined company achieving revenue and cost synergies;
    •
    inability of the combined company to retain and hire key personnel;
    •
    the occurrence of any event that could give rise to termination of the Proposed Transaction;

     


     

    img24726023_0.gif

     

    •
    the risk that shareholder litigation in connection with the Proposed Transaction or other litigation, settlements or investigations may affect the timing or occurrence of the Proposed Transaction or result in significant costs of defense, indemnification and liability;
    •
    evolving legal, regulatory and tax regimes;
    •
    changes in general economic and/or industry specific conditions or any volatility resulting from the imposition of and changing policies, including those policies with respect to tariffs;
    •
    actions by third parties, including government agencies;
    •
    the risk that the anticipated tax treatment of the Proposed Transaction is not obtained;
    •
    the risk of greater than expected difficulty in separating the business of SpinCo from the other businesses of Modine; and
    •
    risks related to the disruption of management time from ongoing business operations due to the pendency of the Proposed Transaction, or other effects of the pendency of the Proposed Transaction on the relationship of any of the parties to the Proposed Transaction with their employees, customers, suppliers, or other counterparties.

    The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time.

     

    Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

    Use of Non-GAAP Financial Measures

    In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding: adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”); Adjusted EBITDA margin; adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”); Quarter-to-date Operating Cash Flow; Free Cash Flow; Adjusted Free Cash Flow; Adjusted Free Cash Flow Conversion rate; net capital expenditures (“net CAPEX”); Net Debt; liquidity; net leverage ratio (“net leverage”); revenue, segment revenue and product revenue excluding foreign currency translation and other specified gains and losses; adjusted operating expenses; Pro Forma Revenue; Pro Forma Adjusted EBITDA and Pro Forma Adjusted EBITDA Margin, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock based compensation expenses, restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted EPS as earnings adjusted by restructuring expenses, net, unrealized currency gain or loss and other gains and losses not reflective of the Company’s ongoing operations and related tax effects. The Company defines Quarter-to-date Operating Cash Flow as Net cash provided by operating activities for the current period less that of the immediately preceding period. The Company defines Free Cash Flow as Net cash provided by operating activities less Purchases of property and equipment. The Company defines net CAPEX as Purchases of property and equipment less Proceeds from the sale of property and equipment. The Company defines Adjusted Free Cash Flow as Net cash provided by operating activities, excluding cash restructuring expenses, net and other gains and losses not reflective of the Company’s ongoing operations, less net CAPEX. The Company defines Adjusted Free Cash Flow Conversion rate as Adjusted Free Cash Flow divided by Adjusted EBITDA. The Company defines Net Debt as the principal amount of all

     


     

    img24726023_0.gif

     

    Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines liquidity as the sum of cash and cash equivalents and availability under the Company’s revolving line of credit. The Company defines Net Leverage as Net Debt divided by Adjusted EBITDA for the trailing four fiscal quarters. The Company defines revenue, segment revenue or product revenue excluding foreign currency translation and other specified gains and losses as such revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates and excluding the other items specified. The Company defines adjusted operating expenses as operating expenses excluding related non-cash stock based compensation, restructuring expenses, net, and other gains and losses not reflective of the Company’s ongoing operations. The Company defines Pro Forma revenue as Gentherm’s product revenues for the trailing four fiscal quarters (from the date specified), plus Modine Performance Technologies’ Net sales for the trailing four fiscal quarters (from the date specified), as reported by Modine Manufacturing Company, adjusted to reflect the latest business structure. The Company defines Pro Forma Adjusted EBITDA as Gentherm’s Adjusted EBITDA for the trailing four fiscal quarters (from the date specified), plus Modine Performance Technologies’ Adjusted EBITDA for the trailing four fiscal quarters (from the date specified), as reported by Modine Manufacturing Company, adjusted to reflect the latest business structure and go-forward operational alignment. The Company defines Pro Forma Adjusted EBITDA Margin as Pro Forma Adjusted EBITDA divided by Pro Forma Revenue.

    The Company’s reconciliations are included in this release or can be found in the supplemental materials on the Company’s website.

    In evaluating its business, the Company considers and uses Quarter-to-date Operating Cash Flow, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Net Debt, Net Leverage and liquidity as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income, revenue or other consolidated income statement or cash flow statement data prepared in accordance with GAAP.

    Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Free Cash Flow, Adjusted Free Cash Flow Conversion rate, Adjusted EPS, Pro Forma Revenue, Pro Forma Adjusted EBITDA and Pro Forma Adjusted EBITDA Margin. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

     

     

     

     


     

    GENTHERM INCORPORATED

    CONSOLIDATED CONDENSED STATEMENTS OF INCOME

    (Dollars in thousands, except per share data)

    (Unaudited)

     

     

     

    Three Months Ended
    December 31,

     

     

    Year Ended
    December 31,

     

     

     

    2025

     

     

    2024

     

     

    2025

     

     

    2024

     

    Product revenues

     

    $

    382,788

     

     

    $

    352,914

     

     

    $

    1,498,602

     

     

    $

    1,456,124

     

    Cost of sales

     

     

    291,987

     

     

     

    266,810

     

     

     

    1,136,426

     

     

     

    1,089,693

     

    Gross margin

     

     

    90,801

     

     

     

    86,104

     

     

     

    362,176

     

     

     

    366,431

     

    Operating expenses:

     

     

     

     

     

     

     

     

     

     

     

     

    Net research and development expenses

     

     

    23,556

     

     

     

    21,078

     

     

     

    94,759

     

     

     

    88,697

     

    Selling, general and administrative expenses

     

     

    47,605

     

     

     

    38,646

     

     

     

    170,045

     

     

     

    155,108

     

    Restructuring expenses, net

     

     

    1,868

     

     

     

    768

     

     

     

    12,476

     

     

     

    13,110

     

    Loss on sale of land and building, net

     

     

    —

     

     

     

    —

     

     

     

    2,196

     

     

     

    —

     

    Impairment of intangible assets and property and equipment

     

     

    —

     

     

     

    1,971

     

     

     

    —

     

     

     

    2,501

     

    Total operating expenses

     

     

    73,029

     

     

     

    62,463

     

     

     

    279,476

     

     

     

    259,416

     

    Operating income

     

     

    17,772

     

     

     

    23,641

     

     

     

    82,700

     

     

     

    107,015

     

    Interest expense, net

     

     

    (2,900

    )

     

     

    (3,344

    )

     

     

    (13,811

    )

     

     

    (15,300

    )

    Foreign currency (loss) gain

     

     

    (1,024

    )

     

     

    15,812

     

     

     

    (28,415

    )

     

     

    9,599

     

    Other (loss) income

     

     

    (3,515

    )

     

     

    (1

    )

     

     

    (4,639

    )

     

     

    951

     

    Earnings before income tax

     

     

    10,333

     

     

     

    36,108

     

     

     

    35,835

     

     

     

    102,265

     

    Income tax expense

     

     

    7,346

     

     

     

    20,787

     

     

     

    17,550

     

     

     

    37,318

     

    Net income

     

    $

    2,987

     

     

    $

    15,321

     

     

    $

    18,285

     

     

    $

    64,947

     

    Basic earnings per share

     

    $

    0.10

     

     

    $

    0.50

     

     

    $

    0.60

     

     

    $

    2.08

     

    Diluted earnings per share

     

    $

    0.10

     

     

    $

    0.49

     

     

    $

    0.59

     

     

    $

    2.06

     

    Weighted average number of shares – basic

     

     

    30,485

     

     

     

    30,912

     

     

     

    30,585

     

     

     

    31,293

     

    Weighted average number of shares – diluted

     

     

    30,939

     

     

     

    31,054

     

     

     

    30,933

     

     

     

    31,476

     

     

     


     

    GENTHERM INCORPORATED

    REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT

    (Dollars in thousands)

    (Unaudited)

     

     

     

    Three Months Ended
    December 31,

     

     

    Year Ended
    December 31,

     

     

     

    2025

     

     

    2024 (a)

     

     

    % Change

     

     

    2025

     

     

    2024 (a)

     

     

    % Change

     

    Climate Control Seats

     

    $

    200,866

     

     

    $

    189,597

     

     

     

    5.9

     %

     

    $

    793,314

     

     

    $

    771,310

     

     

     

    2.9

     %

    Lumbar and Massage Comfort Solutions

     

     

    58,540

     

     

     

    46,260

     

     

     

    26.5

     %

     

     

    212,182

     

     

     

    178,584

     

     

     

    18.8

     %

    Climate Control Interiors

     

     

    50,337

     

     

     

    45,494

     

     

     

    10.6

     %

     

     

    197,901

     

     

     

    186,972

     

     

     

    5.8

     %

    Climate and Comfort Electronics

     

     

    7,444

     

     

     

    4,097

     

     

     

    81.7

     %

     

     

    29,664

     

     

     

    17,363

     

     

     

    70.8

     %

    Automotive Climate and Comfort Solutions

     

     

    317,187

     

     

     

    285,448

     

     

     

    11.1

     %

     

     

    1,233,061

     

     

     

    1,154,229

     

     

     

    6.8

     %

    Valve Systems

     

     

    24,074

     

     

     

    23,082

     

     

     

    4.3

     %

     

     

    96,877

     

     

     

    105,056

     

     

     

    (7.8

    )%

    Other Automotive

     

     

    27,628

     

     

     

    30,304

     

     

     

    (8.8

    )%

     

     

    118,888

     

     

     

    146,993

     

     

     

    (19.1

    )%

    Subtotal Automotive segment

     

     

    368,889

     

     

     

    338,834

     

     

     

    8.9

     %

     

     

    1,448,826

     

     

     

    1,406,278

     

     

     

    3.0

     %

    Medical segment

     

     

    13,899

     

     

     

    14,080

     

     

     

    (1.3

    )%

     

     

    49,776

     

     

     

    49,846

     

     

     

    (0.1

    )%

    Total Company

     

    $

    382,788

     

     

    $

    352,914

     

     

     

    8.5

     %

     

    $

    1,498,602

     

     

    $

    1,456,124

     

     

     

    2.9

     %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Foreign currency translation impact (b)

     

     

    10,019

     

     

     

    —

     

     

     

     

     

     

    16,727

     

     

     

    —

     

     

     

     

    Total Company, excluding foreign
    currency translation impact

     

    $

    372,769

     

     

    $

    352,914

     

     

     

    5.6

     %

     

    $

    1,481,875

     

     

    $

    1,456,124

     

     

     

    1.8

     %

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (a) Prior period product categories have been recast to conform with the current period presentation. See "Revenue by Product Category Historical Recast" table below for additional information.

     

    (b) Foreign currency translation impacts for the three and twelve months ended December 31, 2025, respectively, were as follows: Automotive segment: $9,644 and $16,150; Medical segment: $375, and $577; Automotive Climate and Comfort Solutions: $7,295 and $11,624.

     

     

     


     

    GENTHERM INCORPORATED

    RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA

    AND ADJUSTED EBITDA MARGIN

    (Dollars in thousands)

    (Unaudited)

     

     

     

    Three Months Ended
    December 31,

     

     

    Year Ended
    December 31,

     

     

     

    2025

     

     

    2024

     

     

    2025

     

     

    2024

     

    Net income

     

    $

    2,987

     

     

    $

    15,321

     

     

    $

    18,285

     

     

    $

    64,947

     

    Add back:

     

     

     

     

     

     

     

     

     

     

     

     

    Depreciation and amortization

     

     

    13,783

     

     

     

    12,587

     

     

     

    52,903

     

     

     

    51,329

     

    Income tax expense

     

     

    7,346

     

     

     

    20,787

     

     

     

    17,550

     

     

     

    37,318

     

    Interest expense, net

     

     

    2,900

     

     

     

    3,344

     

     

     

    13,811

     

     

     

    15,300

     

    Adjustments:

     

     

     

     

     

     

     

     

     

     

     

     

    Non-cash stock based compensation

     

     

    1,731

     

     

     

    98

     

     

     

    12,300

     

     

     

    10,432

     

    Restructuring expenses, net

     

     

    1,868

     

     

     

    768

     

     

     

    12,476

     

     

     

    13,110

     

    Unrealized currency (gain) loss

     

     

    (95

    )

     

     

    (16,970

    )

     

     

    30,254

     

     

     

    (10,719

    )

    Merger and acquisition expenses

     

     

    5,706

     

     

     

    —

     

     

     

    6,563

     

     

     

    —

     

    Leadership transition expenses

     

     

    834

     

     

     

    3,802

     

     

     

    3,769

     

     

     

    3,802

     

    Loss on sale of land and building, net

     

     

    —

     

     

     

    —

     

     

     

    2,196

     

     

     

    —

     

    Impairment of intangible assets and property and equipment

     

     

    —

     

     

     

    1,971

     

     

     

    —

     

     

     

    2,501

     

    Non-automotive electronics inventory benefit

     

     

    —

     

     

     

    (103

    )

     

     

    —

     

     

     

    (4,554

    )

    Other loss (gain) (a)

     

     

    3,514

     

     

     

    (231

    )

     

     

    4,712

     

     

     

    (574

    )

    Adjusted EBITDA

     

    $

    40,574

     

     

    $

    41,374

     

     

    $

    174,819

     

     

    $

    182,892

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Product revenues

     

    $

    382,788

     

     

    $

    352,914

     

     

    $

    1,498,602

     

     

    $

    1,456,124

     

    Net income margin

     

     

    0.8

    %

     

     

    4.3

    %

     

     

    1.2

    %

     

     

    4.5

    %

    Adjusted EBITDA margin

     

     

    10.6

    %

     

     

    11.7

    %

     

     

    11.7

    %

     

     

    12.6

    %

     

     

     

     

     

     

     

     

     

     

     

     

     

    (a) Includes $3,647 and $4,941 of non-cash impairment charges related to our non-consolidated equity investments for the three and twelve months ended December 31, 2025.

     

     

     

     


     

    GENTHERM INCORPORATED

    RECONCILIATION OF NET INCOME TO ADJUSTED NET INCOME

    AND ADJUSTED EARNINGS PER SHARE

    (Dollars in thousands, except per share data)

    (Unaudited)

     

     

     

    Three Months Ended
    December 31,

     

     

    Year Ended
    December 31,

     

     

     

    2025

     

     

    2024

     

     

    2025

     

     

    2024

     

    Net income

     

    $

    2,987

     

     

    $

    15,321

     

     

    $

    18,285

     

     

    $

    64,947

     

    Amortization of acquisition related intangibles

     

     

    1,673

     

     

     

    1,572

     

     

     

    6,546

     

     

     

    6,369

     

    Restructuring expenses, net

     

     

    1,868

     

     

     

    768

     

     

     

    12,476

     

     

     

    13,110

     

    Unrealized currency (gain) loss

     

     

    (95

    )

     

     

    (16,970

    )

     

     

    30,254

     

     

     

    (10,719

    )

    Merger and acquisition expenses

     

     

    5,706

     

     

     

    —

     

     

     

    6,563

     

     

     

    —

     

    Leadership transition expenses

     

     

    834

     

     

     

    3,802

     

     

     

    3,769

     

     

     

    3,802

     

    Loss on sale of land and building, net

     

     

    —

     

     

     

    —

     

     

     

    2,196

     

     

     

    —

     

    Impairment of intangible assets and property and equipment

     

     

    —

     

     

     

    1,971

     

     

     

    —

     

     

     

    2,501

     

    Non-automotive electronics inventory benefit

     

     

    —

     

     

     

    (103

    )

     

     

    —

     

     

     

    (4,554

    )

    Other loss (gain) (a)

     

     

    3,513

     

     

     

    (231

    )

     

     

    4,712

     

     

     

    (574

    )

    Tax effect of above

     

     

    (1,293

    )

     

     

    2,964

     

     

     

    (14,716

    )

     

     

    (1,582

    )

    Adjusted net income

     

    $

    15,193

     

     

    $

    9,094

     

     

    $

    70,085

     

     

    $

    73,300

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Weighted average shares outstanding (in thousands):

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

     

    30,485

     

     

     

    30,912

     

     

     

    30,585

     

     

     

    31,293

     

    Diluted

     

     

    30,939

     

     

     

    31,054

     

     

     

    30,933

     

     

     

    31,476

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Earnings per share, as reported:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

    $

    0.10

     

     

    $

    0.50

     

     

    $

    0.60

     

     

    $

    2.08

     

    Diluted

     

    $

    0.10

     

     

    $

    0.49

     

     

    $

    0.59

     

     

    $

    2.06

     

    Adjusted earnings per share:

     

     

     

     

     

     

     

     

     

     

     

     

    Basic

     

    $

    0.50

     

     

    $

    0.29

     

     

    $

    2.29

     

     

    $

    2.34

     

    Diluted

     

    $

    0.49

     

     

    $

    0.29

     

     

    $

    2.27

     

     

    $

    2.33

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    (a) Includes $3,647 and $4,941 of non-cash impairment charges related to our non-consolidated equity investments for the three and twelve months ended December 31, 2025.

     

     

     

     

     


     

    GENTHERM INCORPORATED

    CONSOLIDATED CONDENSED BALANCE SHEETS

    (Dollars in thousands, except share data)

    (Unaudited)

     

     

     

    December 31,

     

     

     

    2025

     

     

    2024

     

    ASSETS

     

     

     

     

     

     

    Current Assets:

     

     

     

     

     

     

    Cash and cash equivalents

     

    $

    160,833

     

     

    $

    134,134

     

    Accounts receivable, net

     

     

    281,083

     

     

     

    258,112

     

    Inventory, net

     

     

    252,702

     

     

     

    227,356

     

    Other current assets

     

     

    82,332

     

     

     

    64,413

     

    Total current assets

     

     

    776,950

     

     

     

    684,015

     

    Property and equipment, net

     

     

    270,614

     

     

     

    252,970

     

    Goodwill

     

     

    108,918

     

     

     

    99,603

     

    Other intangible assets, net

     

     

    52,796

     

     

     

    57,251

     

    Operating lease right-of-use assets

     

     

    56,524

     

     

     

    43,954

     

    Deferred income tax assets

     

     

    93,552

     

     

     

    75,041

     

    Other non-current assets

     

     

    37,075

     

     

     

    34,722

     

    Total assets

     

    $

    1,396,429

     

     

    $

    1,247,556

     

    LIABILITIES AND SHAREHOLDERS’ EQUITY

     

     

     

     

     

     

    Current Liabilities:

     

     

     

     

     

     

    Accounts payable

     

    $

    260,487

     

     

    $

    226,815

     

    Current lease liabilities

     

     

    9,646

     

     

     

    7,517

     

    Current maturities of long-term debt

     

     

    73

     

     

     

    137

     

    Other current liabilities

     

     

    134,104

     

     

     

    105,824

     

    Total current liabilities

     

     

    404,310

     

     

     

    340,293

     

    Long-term debt, less current maturities

     

     

    189,000

     

     

     

    220,064

     

    Non-current lease liabilities

     

     

    48,105

     

     

     

    37,052

     

    Pension benefit obligation

     

     

    3,748

     

     

     

    4,017

     

    Other non-current liabilities

     

     

    30,943

     

     

     

    29,183

     

    Total liabilities

     

    $

    676,106

     

     

    $

    630,609

     

    Shareholders’ equity:

     

     

     

     

     

     

    Common Stock:

     

     

     

     

     

     

    No par value; 55,000,000 shares authorized 30,526,231 and 30,788,639 issued and outstanding at December 31, 2025 and December 31, 2024, respectively

     

     

    5,611

     

     

     

    2,049

     

    Paid-in capital

     

     

    1,590

     

     

     

    4,290

     

    Accumulated other comprehensive loss

     

     

    (964

    )

     

     

    (85,193

    )

    Accumulated earnings

     

     

    714,086

     

     

     

    695,801

     

    Total shareholders’ equity

     

     

    720,323

     

     

     

    616,947

     

    Total liabilities and shareholders’ equity

     

    $

    1,396,429

     

     

    $

    1,247,556

     

     

     


     

    GENTHERM INCORPORATED

    CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

    (Dollars in thousands)

    (Unaudited)

     

     

     

    Year Ended December 31,

     

     

     

    2025

     

     

    2024

     

    Operating Activities:

     

     

     

     

     

     

    Net income

     

    $

    18,285

     

     

    $

    64,947

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

     

     

     

    Depreciation and amortization

     

     

    53,379

     

     

     

    52,975

     

    Deferred income taxes

     

     

    (22,336

    )

     

     

    10,580

     

    Stock based compensation

     

     

    12,300

     

     

     

    10,432

     

    Provisions for inventory

     

     

    6,815

     

     

     

    6,437

     

    Loss (gain) on disposition of property and equipment

     

     

    3,025

     

     

     

    (1,603

    )

    Impairment of intangible assets and property and equipment

     

     

    —

     

     

     

    2,501

     

    Other non-cash items, including unrealized foreign currency loss (gain)

     

     

    34,728

     

     

     

    (1,156

    )

    Changes in assets and liabilities:

     

     

     

     

     

     

    Accounts receivable, net

     

     

    (9,300

    )

     

     

    (12,077

    )

    Inventory

     

     

    (21,629

    )

     

     

    (34,195

    )

    Other assets

     

     

    (17,780

    )

     

     

    (44,696

    )

    Accounts payable

     

     

    27,563

     

     

     

    16,222

     

    Other liabilities

     

     

    31,741

     

     

     

    39,279

     

    Net cash provided by operating activities

     

     

    116,791

     

     

     

    109,646

     

    Investing Activities:

     

     

     

     

     

     

    Purchases of property and equipment

     

     

    (55,673

    )

     

     

    (73,314

    )

    Proceeds from the sale of property and equipment

     

     

    3,770

     

     

     

    7,862

     

    Proceeds from deferred purchase price of factored receivables

     

     

    745

     

     

     

    12,876

     

    Cost of technology investments

     

     

    (1,240

    )

     

     

    (955

    )

    Net cash used in investing activities

     

     

    (52,398

    )

     

     

    (53,531

    )

    Financing Activities:

     

     

     

     

     

     

    Borrowings on debt

     

     

    112,000

     

     

     

    68,000

     

    Repayments of debt

     

     

    (143,149

    )

     

     

    (70,615

    )

    Proceeds from the exercise of Common Stock options

     

     

    —

     

     

     

    5,791

     

    Taxes withheld and paid on employee's share-based payment awards

     

     

    (1,319

    )

     

     

    (3,296

    )

    Cash paid for the repurchase of Common Stock

     

     

    (10,015

    )

     

     

    (51,585

    )

    Net cash used in financing activities

     

     

    (42,483

    )

     

     

    (51,705

    )

    Foreign currency effect

     

     

    4,789

     

     

     

    (19,949

    )

    Net decrease in cash and cash equivalents

     

     

    26,699

     

     

     

    (15,539

    )

    Cash and cash equivalents at beginning of period

     

     

    134,134

     

     

     

    149,673

     

    Cash and cash equivalents at end of period

     

    $

    160,833

     

     

    $

    134,134

     

     

     


     

    GENTHERM INCORPORATED

    OTHER NON-GAAP RECONCILIATIONS

    (Dollars in thousands)

    (Unaudited)

     

     

     

    Three Months Ended December 31,

     

     

    Year ended December 31,

     

     

     

    2025

     

     

    2024

     

     

    2025

     

     

    2024

     

    Total operating expenses

     

    $

    73,029

     

     

    $

    62,463

     

     

    $

    279,476

     

     

    $

    259,416

     

    Restructuring expense, net

     

     

    (1,868

    )

     

     

    (768

    )

     

     

    (12,476

    )

     

     

    (13,110

    )

    Non-cash stock based compensation

     

     

    (1,731

    )

     

     

    (192

    )

     

     

    (11,942

    )

     

     

    (9,909

    )

    Merger and acquisition expenses

     

     

    (5,706

    )

     

     

    —

     

     

     

    (6,563

    )

     

     

    —

     

    Leadership transition expenses

     

     

    (834

    )

     

     

    (3,802

    )

     

     

    (3,769

    )

     

     

    (3,802

    )

    Loss on sale of land and building, net

     

     

    —

     

     

     

    —

     

     

     

    (2,196

    )

     

     

    —

     

    Impairment of intangible assets and property and equipment

     

     

    —

     

     

     

    (1,971

    )

     

     

    —

     

     

     

    (2,501

    )

    Other gain (loss)

     

     

    —

     

     

     

    231

     

     

     

    (70

    )

     

     

    (990

    )

    Adjusted operating expenses

     

    $

    62,890

     

     

    $

    55,961

     

     

    $

    242,460

     

     

    $

    229,104

     

     

     

     

     

     

    December 31, 2025

     

     

    December 31, 2024

     

    Cash and cash equivalents

     

    $

    160,833

     

     

    $

    134,134

     

    Revolving line of credit availability

     

     

    307,935

     

     

     

    280,000

     

    Total liquidity

     

    $

    468,768

     

     

    $

    414,134

     

     

     

     

     

     

    December 31, 2025

     

     

    December 31, 2024

     

    Current maturities of long-term debt

     

    $

    73

     

     

    $

    137

     

    Long-term debt, less current maturities

     

     

    189,000

     

     

     

    220,064

     

    Total Debt

     

     

    189,073

     

     

     

    220,201

     

    Cash and cash equivalents

     

     

    160,833

     

     

     

    134,134

     

    Net Debt

     

    $

    28,240

     

     

    $

    86,067

     

     

     

     

     

     

     

     

    Adjusted EBITDA

     

    $

    174,819

     

     

    $

    182,892

     

    Net Leverage

     

     

    0.2

     

     

     

    0.5

     

     

     


     

    GENTHERM INCORPORATED

    REVENUE BY PRODUCT CATEGORY HISTORICAL RECAST

    (Dollars in thousands)

    (Unaudited)

    Product categories have been modified, and prior-period amounts have been recast to conform with the current period presentation. Climate Control Seat (CCS®) includes CCS Heat (previously Seat Heaters), CCS Vent/CCS Active Cool (previously CCS) and CCS Neck Conditioners (previously included in Other Automotive). Climate Control Interiors (CCITM) includes CCI Steering Wheel Heat and CCI Interior Heat (previously included in Other Automotive). Other Automotive includes Automotive Cables, Battery Performance Solutions, non-automotive electronics and contract manufacturing electronics (previously classified as Electronics).

    The table below shows the prior period amounts on a quarterly basis for the years 2023 and 2024 recast to conform with the current presentation:

     

     

     

    2023

     

     

     

    Q1

     

     

    Q2

     

     

    Q3

     

     

    Q4

     

     

    Full Year

     

    Climate Control Seats

     

    $

    193,395

     

     

    $

    199,780

     

     

    $

    201,221

     

     

    $

    203,192

     

     

    $

    797,588

     

    Climate Control Interiors

     

     

    42,947

     

     

     

    46,084

     

     

     

    45,398

     

     

     

    43,547

     

     

     

    177,976

     

    Lumbar and Massage Comfort Solutions

     

     

    38,738

     

     

     

    37,604

     

     

     

    33,260

     

     

     

    35,321

     

     

     

    144,923

     

    Climate and Comfort Electronics

     

     

    3,539

     

     

     

    2,277

     

     

     

    2,842

     

     

     

    4,202

     

     

     

    12,860

     

    Automotive Climate and Comfort Solutions

     

     

    278,619

     

     

     

    285,745

     

     

     

    282,721

     

     

     

    286,262

     

     

     

    1,133,347

     

    Valve Systems

     

     

    26,994

     

     

     

    27,692

     

     

     

    27,830

     

     

     

    23,746

     

     

     

    106,262

     

    Other Automotive

     

     

    47,079

     

     

     

    48,096

     

     

     

    44,231

     

     

     

    43,937

     

     

     

    183,343

     

    Subtotal Automotive segment

     

     

    352,692

     

     

     

    361,533

     

     

     

    354,782

     

     

     

    353,945

     

     

     

    1,422,952

     

    Medical segment

     

     

    10,933

     

     

     

    10,790

     

     

     

    11,413

     

     

     

    12,988

     

     

     

    46,124

     

    Total Company

     

    $

    363,625

     

     

    $

    372,323

     

     

    $

    366,195

     

     

    $

    366,933

     

     

    $

    1,469,076

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    2024

     

     

     

    Q1

     

     

    Q2

     

     

    Q3

     

     

    Q4

     

     

    Full Year

     

    Climate Control Seats

     

    $

    192,049

     

     

    $

    199,766

     

     

    $

    189,898

     

     

    $

    189,597

     

     

    $

    771,310

     

    Climate Control Interiors

     

     

    44,398

     

     

     

    47,031

     

     

     

    49,283

     

     

     

    46,260

     

     

     

    186,972

     

    Lumbar and Massage Comfort Solutions

     

     

    38,251

     

     

     

    45,869

     

     

     

    48,970

     

     

     

    45,494

     

     

     

    178,584

     

    Climate and Comfort Electronics

     

     

    4,226

     

     

     

    4,157

     

     

     

    4,883

     

     

     

    4,097

     

     

     

    17,363

     

    Automotive Climate and Comfort Solutions

     

     

    278,924

     

     

     

    296,823

     

     

     

    293,034

     

     

     

    285,448

     

     

     

    1,154,229

     

    Valve Systems

     

     

    26,625

     

     

     

    29,267

     

     

     

    26,082

     

     

     

    23,082

     

     

     

    105,056

     

    Other Automotive

     

     

    39,089

     

     

     

    37,912

     

     

     

    39,688

     

     

     

    30,304

     

     

     

    146,993

     

    Subtotal Automotive segment

     

     

    344,638

     

     

     

    364,002

     

     

     

    358,804

     

     

     

    338,834

     

     

     

    1,406,278

     

    Medical segment

     

     

    11,377

     

     

     

    11,681

     

     

     

    12,708

     

     

     

    14,080

     

     

     

    49,846

     

    Total Company

     

    $

    356,015

     

     

    $

    375,683

     

     

    $

    371,512

     

     

    $

    352,914

     

     

    $

    1,456,124

     

     

     


    Get the next $THRM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $THRM

    DatePrice TargetRatingAnalyst
    10/21/2024$56.00Underweight → Neutral
    JP Morgan
    12/4/2023Buy → Hold
    Argus
    7/11/2023$73.00 → $65.00Outperform → Neutral
    Robert W. Baird
    10/27/2021$105.00Buy
    Seaport Global
    9/22/2021$94.00Outperform
    Robert W. Baird
    9/22/2021$94.00Outperform
    Baird
    7/30/2021$85.00 → $92.00Buy
    Roth Capital
    7/30/2021$70.00 → $110.00Hold → Buy
    Craig Hallum
    More analyst ratings

    $THRM
    SEC Filings

    View All

    SEC Form 425 filed by Gentherm Inc

    425 - Gentherm Inc (0000903129) (Subject)

    2/19/26 5:14:16 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    SEC Form 425 filed by Gentherm Inc

    425 - Gentherm Inc (0000903129) (Subject)

    2/19/26 5:07:11 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    SEC Form 425 filed by Gentherm Inc

    425 - Gentherm Inc (0000903129) (Subject)

    2/19/26 4:55:35 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    $THRM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Gentherm Reports 2025 Fourth Quarter and Full Year Results

    Achieved Record Annual Revenue of $1.5 Billion  Increased Full Year Operating Cash Flow 7% Year-over-Year; Reduced Net Leverage to 0.2x Establishes 2026 Guidance; Provides Preliminary Revenue Outlook of ~$1.7B for 2027 NOVI, Mich., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced its financial results for the fourth quarter and full year ended December 31, 2025. "We made significant progress on our long-term strategic initiatives while executing against our 2025 financial and operational plans. We are intent on transforming Gentherm. Momentum on our adjacent mark

    2/19/26 6:00:00 AM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Gentherm Announces Date for 2025 Fourth Quarter and Year-End Results News Release and Conference Call

    NOVI, Mich., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the fourth quarter and year-end 2025 on Thursday, February 19, 2026, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13758613 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm's website at www.gentherm.com. A telephonic replay will be availab

    2/5/26 8:30:00 AM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Gentherm Announces FDA 510(k) Submission for Innovative Technology Expected to Promote Safer Surgeries and Better Patient Outcomes

    NOVI, Mich., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM) a global market leader of innovative thermal management and pneumatic comfort technologies, today announced it submitted a 510(k) Class II premarket notification to the U.S. Food and Drug Administration (FDA) for ThermAffyx™ Patient Safety System, an integrated patient warming and securement system. Two leading patient safety concerns during robotic surgery are maintaining patient temperature and preventing patient movement while on the operating room table. The first of its kind ThermAffyx™ System combines air-free patient warming with securement technology to help prevent both hypothermia and patient movement during p

    2/3/26 8:30:00 AM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    $THRM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Technology Officer Sundaram Vishnu covered exercise/tax liability with 1,242 shares, decreasing direct ownership by 5% to 21,905 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    9/30/25 4:13:56 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Chief Accounting Officer Nicholas Breisacher covered exercise/tax liability with 38 shares, decreasing direct ownership by 0.89% to 4,223 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    8/29/25 4:18:47 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    SVP, CHRO Runyon Barbara J sold $116,577 worth of shares (3,348 units at $34.82), decreasing direct ownership by 10% to 31,316 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    8/25/25 4:28:48 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    $THRM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Washington Kenneth E bought $47,702 worth of shares (1,700 units at $28.06), increasing direct ownership by 18% to 10,965 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    5/13/25 4:10:38 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Director Hundzinski Ronald T bought $133,350 worth of shares (5,000 units at $26.67), increasing direct ownership by 38% to 18,006 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    5/12/25 4:06:43 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    SVP, General Manager, Europe Stocker Thomas bought $8,011 worth of shares (321 units at $24.96), increasing direct ownership by 2% to 20,638 units (SEC Form 4)

    4 - Gentherm Inc (0000903129) (Issuer)

    4/29/25 8:46:29 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    $THRM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Gentherm upgraded by JP Morgan with a new price target

    JP Morgan upgraded Gentherm from Underweight to Neutral and set a new price target of $56.00

    10/21/24 8:28:24 AM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Gentherm downgraded by Argus

    Argus downgraded Gentherm from Buy to Hold

    12/4/23 8:01:12 AM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Gentherm downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded Gentherm from Outperform to Neutral and set a new price target of $65.00 from $73.00 previously

    7/11/23 7:38:23 AM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    $THRM
    Leadership Updates

    Live Leadership Updates

    View All

    Sleep Number Board Names Linda Findley as President and Chief Executive Officer

    Findley has a demonstrated record of accelerating growth and transformation across diverse consumer business models Phillip Eyler to become independent Board Chair, effective after the 2025 Annual Meeting of Shareholders Sleep Number Corporation (NASDAQ:SNBR) today announced that its Board of Directors (the "Board") has appointed Linda Findley as the company's new President and Chief Executive Officer, and as a member of the Board, effective April 7, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250305807579/en/Linda Findley will assume the role of Sleep Number President and CEO on April 7, 2025 (Photo: Business Wire) Fi

    3/5/25 4:15:00 PM ET
    $APRN
    $ETSY
    $RL
    Catalog/Specialty Distribution
    Consumer Discretionary
    Real Estate
    Garments and Clothing

    Gentherm Names Jonathan Douyard as Executive Vice President, Chief Financial Officer and Treasurer

    NORTHVILLE, Mich., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Jonathan ("Jon") Douyard will join the Company's leadership team as Executive Vice President, Chief Financial Officer and Treasurer, effective January 1, 2025. Douyard will lead all of Gentherm's finance, treasury, investor relations, and IT operations on a global basis, reporting to Gentherm's next President and CEO, Bill Presley. Douyard succeeds Matteo Anversa, who served as CFO until September 2024 when he

    11/21/24 4:30:00 PM ET
    $SHYF
    $THRM
    Auto Manufacturing
    Consumer Discretionary
    Auto Parts:O.E.M.

    Gentherm Announces Dr. Ken Washington as New Independent Director

    NORTHVILLE, Mich., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken Washington has been appointed to the Company's Board of Directors, effective October 2, 2023. Dr. Washington is the Senior Vice President, Chief Technology and Innovation Officer of Medtronic plc (NYSE:MDT), a global healthcare technology company that provides device-based medical therapies and services. He was appointed to this position in June 2023, and he leads innovation and the expansion of technol

    10/2/23 8:00:00 AM ET
    $AMZN
    $F
    $MCK
    Catalog/Specialty Distribution
    Consumer Discretionary
    Auto Manufacturing
    Industrials

    $THRM
    Financials

    Live finance-specific insights

    View All

    Gentherm Reports 2025 Fourth Quarter and Full Year Results

    Achieved Record Annual Revenue of $1.5 Billion  Increased Full Year Operating Cash Flow 7% Year-over-Year; Reduced Net Leverage to 0.2x Establishes 2026 Guidance; Provides Preliminary Revenue Outlook of ~$1.7B for 2027 NOVI, Mich., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced its financial results for the fourth quarter and full year ended December 31, 2025. "We made significant progress on our long-term strategic initiatives while executing against our 2025 financial and operational plans. We are intent on transforming Gentherm. Momentum on our adjacent mark

    2/19/26 6:00:00 AM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Gentherm Announces Date for 2025 Fourth Quarter and Year-End Results News Release and Conference Call

    NOVI, Mich., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, will report its financial results for the fourth quarter and year-end 2025 on Thursday, February 19, 2026, and will host a conference call to discuss those results at 8 am (ET) that same day. Conference CallToll-free dial-in number: 1-877-407-4018International dial-in number: 1-201-689-8471Conference ID number: 13758613 WebcastA live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor Relations section of Gentherm's website at www.gentherm.com. A telephonic replay will be availab

    2/5/26 8:30:00 AM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    Gentherm and Modine's Performance Technologies Business to Combine, Establishing a Scaled Leader in Thermal Management Solutions

    Expands Gentherm's portfolio with highly complementary thermal management products and engineering capabilities, creating strong commercial opportunities in attractive end markets including power generation, commercial vehicles, and heavy-duty equipmentCreates a compelling and more balanced financial profile for the combined company including lower light vehicle exposure, greater scale, substantial synergies, and a balance sheet with capacity to invest in future growthReverse Morris Trust transaction valued at ~$1.0 billion,1 ~6.8x post-synergy adjusted EBITDA2,3,4 with Modine and Gentherm shareholders expected to own 40% and 60% of the combined company, respectively Accelerates the transfor

    1/29/26 7:00:00 AM ET
    $MOD
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    $THRM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Gentherm Inc (Amendment)

    SC 13G/A - GENTHERM Inc (0000903129) (Subject)

    2/13/24 5:06:25 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    SEC Form SC 13G filed by Gentherm Inc

    SC 13G - GENTHERM Inc (0000903129) (Subject)

    2/9/24 11:21:57 AM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary

    SEC Form SC 13G/A filed by Gentherm Inc (Amendment)

    SC 13G/A - GENTHERM Inc (0000903129) (Subject)

    2/14/22 2:34:21 PM ET
    $THRM
    Auto Parts:O.E.M.
    Consumer Discretionary